MRC1 and cancer: Emerging evidence highlights how DNA repair alterations, beyond MMR, can create a permissive microenvironment by (a) triggering intracellular pathways that developed to restrict pathogen infection and are capable of unleashing the immune system against cancer cells; (b) inducing immunogenic cell death or autophagy in cancer cells; and (c) modulating immune checkpoint molecules, thereby allowing ICB engagement.